Back to Search
Start Over
Particulate matters induce acute exacerbation of allergic airway inflammation via the TLR2/NF-κB/NLRP3 signaling pathway
- Source :
- Toxicology Letters. 321:146-154
- Publication Year :
- 2020
- Publisher :
- Elsevier BV, 2020.
-
Abstract
- Background Exposure to particulate matters (PMs) can lead to an acute exacerbation of allergic airway diseases, increasing the severity of symptoms and mortality. However, little is known about the underlying molecular mechanism. This study aimed to investigate the effects of PMs on acute exacerbation of allergic airway inflammation and seek potential therapeutic targets. Methods Non-allergic control and ovalbumin (OVA)-allergic wide-type (WT) and Toll-like receptor 2 knockout (Tlr2-/-) mice were exposed to 100 μg of PM (diameter 5.85 μm) or saline by the oropharyngeal instillation. The responses were examined three days after exposure. In the RAW264.7 macrophage cell line, Tlr2 was knocked down by small-interfering RNA or the NF-κB inhibitor JSH-23 was used, and then the cells were stimulated with PMs for 12 h before comparison of the inflammatory responses. Results PM exposure led to increased inflammatory cell recruitment and airway intensity of PAS + staining in OVA-allergic WT mice, accompanied with an accumulation of inflammatory cells and elevated inflammatory cytokines, such as IL-6 and IL-18, in the bronchoalveolar lavage fluid (BALF). Furthermore, the protein levels of TLR2 and the NLRP3 inflammasome were elevated concomitantly with the airway inflammation post-OVA/PMs challenge. Tlr2 deficiency effectively inhibited the airway inflammation, including pulmonary inflammatory cell recruitment, mucus secretion, serum OVA-specific immunoglobulin E (IgE), and BALF inflammatory cytokine production. Additionally, the P-induced NLRP3 activation in the RAW 264.7 cell line was diminished by the knockdown of Tlr2 or JSH-23 treatment in vitro. Conclusion Our results indicated that PMs exacerbate the allergic airway inflammation mediated by the TLR2/ NF-κB/NLRP3 signaling pathway. Inhibition of NF-κB seems to be a possible treatment.
- Subjects :
- 0301 basic medicine
Exacerbation
Ovalbumin
medicine.medical_treatment
Toxicology
Immunoglobulin E
Proinflammatory cytokine
Mice
03 medical and health sciences
0302 clinical medicine
NLR Family, Pyrin Domain-Containing 3 Protein
Respiratory Hypersensitivity
medicine
Animals
Particle Size
Lung
Mice, Knockout
medicine.diagnostic_test
biology
business.industry
Macrophages
NF-kappa B
Inflammasome
General Medicine
Allergens
respiratory system
Toll-Like Receptor 2
Mice, Inbred C57BL
Disease Models, Animal
TLR2
RAW 264.7 Cells
030104 developmental biology
Bronchoalveolar lavage
Cytokine
Immunology
Disease Progression
biology.protein
Cytokines
Female
Particulate Matter
business
030217 neurology & neurosurgery
Signal Transduction
medicine.drug
Subjects
Details
- ISSN :
- 03784274
- Volume :
- 321
- Database :
- OpenAIRE
- Journal :
- Toxicology Letters
- Accession number :
- edsair.doi.dedup.....9a3c02d0e573dd8f4e79b6b724b9bd08
- Full Text :
- https://doi.org/10.1016/j.toxlet.2019.12.013